Key facts
- This page summarizes Robert Barrow's Form 4 filing for Mind Medicine (MindMed) Inc. (MNMD).
- 2 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 27 Jun 2023, 19:41.
Robert Barrow - 27 Jun 2023 Form 4 Insider Report for Mind Medicine (MindMed) Inc. (MNMD)
- Reporting relationship
- Chief Executive Officer, Director
- Issuer ticker
- MNMD
- Reported as of
- 27 Jun 2023
- Net transaction value
- -$49,620
- SEC form
- 4
- Accepted by SEC
- 27 Jun 2023, 19:41:45 UTC
- Prior SEC filing
- 17 Mar 2023
- Next SEC filing
- 25 Sep 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Carrie Liao, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Robert Barrow filed Form 4 for Mind Medicine (MindMed) Inc. (MNMD) on 27 Jun 2023.
Change
- Previous filing in this sequence was filed on 17 Mar 2023.
- Current net transaction value: -$49,620.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
MNMD
transaction
Common Shares
Sale
- Transaction value
- $22,604
- Shares
- -7,086
- Change %
- -1.1%
- Price
- $3.19
- Shares after
- 631,873
- Date
- 27 Jun 2023
- Ownership
- Direct
- Footnotes
- F1, F2
MNMD
transaction
Common Shares
Sale
- Transaction value
- $27,015
- Shares
- -8,416
- Change %
- -1.3%
- Price
- $3.21
- Shares after
- 623,457
- Date
- 27 Jun 2023
- Ownership
- Direct
- Footnotes
- F1, F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
Represents the number of Common Shares sold to satisfy withholding tax obligations in connection with the settlement of vested restricted stock units, pursuant to sell-to-cover elections.
Footnote F2
The reported price is a weighted average sales price. This represents the price in United States Dollars using the conversion rate on June 27, 2023. These shares were sold in multiple transactions on June 27, 2023 at prices ranging from $4.20 to $4.23 CAD Dollars. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Footnote F3
The reported price is a weighted average sales price. These shares were sold in multiple transactions on June 27, 2023 at prices ranging from $3.20 to $3.23 US Dollars. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.